European Drug Report 2017

European Drug Report 2017

European Drug Report 2017

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions will be explored on 6 June in our annual overview of the European drug situation. #EDR2017

Launch details

Date: 6 June 2017
Time: 11:45 Western European Time (Lisbon) (12:45 Central European Time) Venue: European Commission, press room, Berlaymont, Brussels

Package

The full package will be available 6 June 2017.

 

Download the report

Available 6 June 2017.

Press material

Press material will be added here as it becomes available.

The European Drug Report 2017: Trends and Developments, provides a comprehensive analysis of the latest tendencies across the 28 EU Member States, Turkey and Norway. In print and pdf in 24 languages, the report examines: drug supply and the market; drug use prevalence and trends; and drug-related harms and responses to them. Accompanying the report will be the 2017 Statistical Bulletin, containing the European dataset underpinning the analysis.

The report will be complemented for the first time by 30 Country Drug Reports, presenting summaries of national drug phenomena (EU 28, Turkey and Norway). Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

Finding out more about the launch in News release 4/2017.

Audiovisual material

Available 6 June 2017.

National launches

Available 6 June 2017.